Looking for a buyer.
This Company is the founder and holding company for the group of innovative brands that appeal to both the local market in South Africa and International Markets. Its most prominent consumer brand has the potential to yield the highest ROI, benefitting the other brands within the corporate umbrella. This proposal will focus on how the company’s consumer brand can generate high ROI and deliver value and returns to investors. The multi-billion-dollar dental industry is ever-growing and the company is ambitious and want their brand to be the global standard. The Company has grown organically for the past two years, but they have ambitious goals that include expanding into retail outlets across North America. Currently, there exists strong partnerships between the Company and distributors in the UK and locally in South Africa. Shortly after this transaction closes, North American distribution and retail channels will be launched. The funds will be used for the marketing and growth of the Company’s consumer product, which ultimately provides partners with an opportunity to share in its profits. Global investment in this company will not only benefit prospective buyers within one country, but also across multiple geographical areas, allowing for an even greater reach of all parties involved. NDA is required to secure comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners. Detailed Information Competition: There exists some competition in the dental instruments industry in the world; however, this Company is looking to expand its footprint in the marketplace with a unique product that is ready to disrupt this ever-growing global industry. This industry is poised to grow from $6.9b in 2022 to $9.14b in 2029 at a CAGR (compound annual growth rate) of 4.1%. The Company is well-positioned with a proven product to capitalize on this ever-growing market. Growth & Expansion: The Company will expand distribution in North America and UK, with future plans to expand to other countries such as Australia, Singapore, Netherlands, and Germany. The Company has identified three strategic partners to execute expansion plans in the aforementioned markets. The Company will the proceeds from the sale to enhance manufacturing, marketing and branding, future product design and manufacturing, and sales and distribution. Financing: If the price and deal structure is right. Support & Training: The executive team will continue to operate and expand the business. Long term transition plan preferred by Sellers. Reason for Selling: The Company is looking to grow with the Buyer's team.

listing type
exclusive representation
industry
Healthcare
location
New York, NY, USA
revenue
$1,550,000
ebitda
$147,259
proposed price
$2,000,000
To download teaser or contact poster, please sign in.